Cefprozil labels and packages

Jump to navigation Jump to search
Cefprozil
CEFZIL®,CEFPROZIL® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Overdosage
Dosage and Administration
Clinical Studies
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Abdurahman Khalil, M.D. [2]


Labels and Packaging

Clinitest® and Clinistix® are registered trademarks of the Bayer HealthCare LLC.

01-2008

Manufactured in Austria by Sandoz GmbH

for Sandoz Inc., Princeton, NJ 08540

250 mg Tablet Label

File:Cefp1.jpg

NDC 0781-5043-01

Cefprozil

Tablets, USP

250 mg*

(Film-Coated Tablets)

Rx only

100 Tablets

SANDOZ

500 mg Tablet Label

NDC 0781-5044-50

Cefprozil

Tablets, USP

500 mg*

(Film-Coated Tablets)

Rx only

50 Tablets

SANDOZ

125 mg 5 mL Oral Suspension Label

NDC 0781-6202-91

Cefprozil

for Oral

Suspension, USP

125 mg/5 mL*

when constituted

according to directions

Rx only

50 mL

(when mixed)

SANDOZ

250 mg 5 mL Oral Suspension Label

NDC 0781-6203-91

Cefprozil

for Oral

Suspension, USP

250 mg/5 mL*

when constituted

according to directions

Rx only

50 mL

(when mixed)

SANDOZ

References

http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/050664s024,050665s024lbl.pdf